4.5 Article

Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

The State of the Art in the Development of Biosimilars

Mark McCamish et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)

Article Chemistry, Medicinal

The Utility of Hydrogen/Deuterium Exchange Mass Spectrometry in Biopharmaceutical Comparability Studies

Damian Houde et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2011)

Letter Biotechnology & Applied Microbiology

Acceptable changes in quality attributes of glycosylated biopharmaceuticals

Martin Schiestl et al.

NATURE BIOTECHNOLOGY (2011)

Article Biotechnology & Applied Microbiology

Advances in the assessment and control of the effector functions of therapeutic antibodies

Xu-Rong Jiang et al.

NATURE REVIEWS DRUG DISCOVERY (2011)

Editorial Material Chemistry, Multidisciplinary

Strategies for the Assessment of Protein Aggregates in Pharmaceutical Biotech Product Development

John den Engelsman et al.

PHARMACEUTICAL RESEARCH (2011)

Article Biotechnology & Applied Microbiology

Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins

Darius Ghaderi et al.

NATURE BIOTECHNOLOGY (2010)

Article Biochemical Research Methods

Expression of soluble and functional human neonatal Fc receptor in Pichia pastoris

Chang-Han Lee et al.

PROTEIN EXPRESSION AND PURIFICATION (2010)

Article Hematology

Rituximab: Mechanism of Action

George J. Weiner

SEMINARS IN HEMATOLOGY (2010)

Article Chemistry, Analytical

Analysis of Protein Conformation and Dynamics by Hydrogen/Deuterium Exchange MS

John R. Engen

ANALYTICAL CHEMISTRY (2009)

Review Biochemistry & Molecular Biology

Optimal and consistent protein glycosylation in mammalian cell culture

Patrick Hossler et al.

GLYCOBIOLOGY (2009)

Article Chemistry, Analytical

Unveiling a glycation hot spot in a recombinant humanized monoclonal antibody

Boyan Zhang et al.

ANALYTICAL CHEMISTRY (2008)

Review Immunology

Anti-inflammatory actions of intravenous immunoglobulin

Falk Nimmerjahn et al.

ANNUAL REVIEW OF IMMUNOLOGY (2008)

Review Biochemistry & Molecular Biology

The Galα1,3Galβ1,4GlcNAc-R (α-Gal) epitope:: A carbohydrate of unique evolution and clinical relevance

Bruce A. Macher et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2008)

Review Biochemistry & Molecular Biology

Trends in Glycosylation, Glycoanalysis and Glycoengineering of Therapeutic Antibodies and Fc-Fusion Proteins

Alain Beck et al.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2008)

Article Medicine, General & Internal

Cetuximab-induced anaphylaxis and IgE specific for galactose-α-1,3-galactose

Christine H. Chung et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Biochemical Research Methods

Comparison of methionine oxidation in thermal stability and chemically stressed samples of a fully human monoclonal antibody

Chris Churnsae et al.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)

Article Biochemical Research Methods

Cation exchange-HPLC and mass spectrometry reveal C-terminal amidation of an IgG1 heavy chain

Keith A. Johnson et al.

ANALYTICAL BIOCHEMISTRY (2007)

Review Immunology

FcRn: the neonatal Fc receptor comes of age

Derry C. Roopenian et al.

NATURE REVIEWS IMMUNOLOGY (2007)

Article Pharmacology & Pharmacy

Effects of protein aggregates: An immunologic perspective

Amy S. Rosenberg

AAPS JOURNAL (2006)

Article Biochemistry & Molecular Biology

Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity

RL Shields et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Article Biochemistry & Molecular Biology

Role of oligosaccharide residues of IgG1-Fc in FcγRIIb binding

Y Mimura et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)